Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 1917-1922

  Steuber, Thomas ^a   Nurmikko, Pauliina ^a   Haese, Alexander ^a   Pettersson, Kim ^a   Graefen, Markus ^a   Hammerer, Peter ^a   Huland, Hartwig ^a   Lilja, Hans ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Diagnosis; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CALCULATION; CANCER DIAGNOSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; ROC CURVE;

EID: 0036837259     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64263-2     Document Type: Article

References (26)

1. Stephenson, R. A. and Stanford, J. L.: Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J Urol, 15: 331, 1997
2. Oesterling, J. E.: Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol, 145: 907, 1991
3. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A. et al: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 270: 860, 1993
4. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R. et al: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA, 267: 2215, 1992
5. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol, 147: 817, 1992
6. Luderer, A. A., Chen, Y. T., Soriano, T. F., Kramp, W. J., Carlson, G., Cuny, C. et al: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology, 46: 187, 1995
7. Christensson, A. and Lilja, H.: Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur J Biochem, 220: 45, 1994
8. Leinonen, J., Zhang, W. M. and Stenman, U. H.: Complex formation between PSA isoenzymes and protease inhibitors. J Urol, 155: 1099, 1996
9. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K. et al: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem, 37: 1618, 1991
10. Christensson, A., Laurell, C, B. and Lilja, H.: Enzymatic activity of pros tate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem, 194: 755, 1990
11. Heeb, M. J., Espana, F., Gittes, R. F. and Griffin, J. H.: Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera. Biochem Mol Biol Int, 37: 917, 1995
12. Zhang, W. M., Leinonen, J., Kalkkinen, N., Dowell, B. and Stenman, U. H.: Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem, 41: 1567, 1995
13. Mikolajczyk, S. D., Grauer, L. S., Millar, L. S., Hill, T. M., Kumar, A., Rittenhouse, H. G. et al: A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology, 50: 710, 1997
14. Mikolajczyk, S. D., Millar, L. S., Wang, T. J., Rittenhouse, H. G., Marks, L. S., Song, W. et al: A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue. Cancer Res, 60: 756, 2000
15. Mikolajczyk, S. D., Marker, K. M., Millar, L. S., Kumar, A., Saedi, M. S., Payne, J. K. et al: A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Cancer Res, 61: 6958, 2001
16. Mikolajczyk, S. D., Millar, L. S., Marker, K. M., Wang, T. J., Rittenhouse, H. G., Marks, L. S. et al: Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia. Prostate, 45: 271, 2000
17. Mikolajczyk, S. D., Millar, L. S., Wang, T. J., Rittenhouse, H. G., Wolfert, R. L., Marks, L. S. et al: "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology, 55: 41, 2000
18. Noldus, J., Chen, Z. and Stamey, T. A.: Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer. J Urol, 158: 1606, 1997
19. Visage, V. L. J., Hellmann, J., Pinioned, T., Lilja, H. and Pettersson, K.: Characterization processing of prostate specific antigen (hk3) and human glandular kallikrein (hk2) secreted by LNCaP cells. Unpublished data
20. Nurmikko, P., Vaisanen, V., Piironen, T., Lindgren, S., Lilja, H. and Pettersson, K.: Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA. Clin Chem, 46: 1610, 2000
21. Nurmikko, P., Pettersson, K., Piironen, T., Hugosson, J. and Lilja, H.: Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. Clin Chem, 47: 1415, 2001
22. Mitrunen, K., Pettersson, K., Piironen, T., Bjork, T., Lilja, H. and Lovgren, T.: Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. Clin Chem, 41: 1115, 1995
23. Kairisto, V. and Poola, A.: Software for illustrative presentation of basic clinical characteristics of laboratory tests-GraphROC for Windows. Scand J Clin Lab Invest, 222: 43, 1995
24. Lilja, H.: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest, 76: 1899, 1985
25. Takayama, T. K., Fujikawa, K. and Davie, E. W.: Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J Biol Chem, 272: 21582, 1997
26. Charrier, J. P., Tournel, C., Michel, S., Comby, S., Jolivet-Reynaud, C., Passagot, J. et al: Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis. Electrophoresis, 22: 1861, 2001